Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
UltraSight Granted Patent for Real-Time Guidance Ultrasound Technology
UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, […]
ArisGlobal Signs Agreement to Acquire Amplexor Life Sciences
ArisGlobal, the leading provider of life sciences software designed to automate core drug development functions […]
Maven Clinic Announces New Clinical Research and Investments in Innovation to Advance Care Model for Women's and Family Health
Maven Clinic, the world’s largest virtual clinic for women’s and family health, has announced several […]
GenScript Expands Footprint in Singapore to Provide Premium Gene Synthesis Service
GenScript Biotech Corporation, the world’s leading provider of life-science research tools and services, announced the […]
mdgroup Launches Third Fully Compliant Medical Distribution Centre in Amsterdam
mdgroup, a leading global MedTech and patient health services company pioneering a patient-first approach to […]
M8 Pharmaceuticals and Daewoong Pharmaceutical Sign Exclusive Licensing Agreement for Envlo™ for Brazil and Mexico
M8 Pharmaceuticals and Daewoong Pharmaceuticals announced they have signed an exclusive licensing agreement whereby M8 […]
Ellodi Pharmaceuticals Welcomes Debra Silberg MD, PhD, FACG to its Board of Directors
Ellodi Pharmaceuticals, a gastroenterology-focused specialty pharmaceutical company dedicated to the continued development of APT-1011, a […]
Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration
Eisai and Biogen announced today that the Biologics License Application (BLA) for lecanemab, an investigational […]
Action Plan to Tackle Health Inequalities for People Living with Rare Diseases
A new Rare Diseases Action Plan for England will be published today and will ensure […]
Maze Therapeutics Announces Positive Phase 1 Results from First-in-Human Trial Evaluating MZE001 as a Potential Oral Treatment for Pompe Disease
Maze Therapeutics, a company translating genetic insights into new precision medicines, has announced positive results […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more